You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 153 No. 6, June 1999 TABLE OF CONTENTS
  Archives
  •  Online Features
  Article
 This Article
 •Full text
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (11)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Bacterial Infections
 •Infectious Diseases
 •Alert me on articles by topic

Bacterial Infections in Infants 60 Days and Younger

Epidemiology, Resistance, and Implications for Treatment

Karin Berger Sadow, MD; Robert Derr, MD; Stephen J. Teach, MD, MPH

Arch Pediatr Adolesc Med. 1999;153:611-614.

Objective  To establish what might be more optimal initial antibiotic therapy for suspected invasive bacterial infections in infants 60 days or younger who are evaluated in the emergency department (ED).

Setting  Urban university-affiliated pediatric referral center with an average yearly ED census of 52,000 visits during the study period.

Design and Methods  We assembled a retrospective case series of all positive blood, urine, and cerebrospinal fluid cultures in children 60 days or younger from January 1, 1994, through December 31, 1997, obtained from both inpatients and patients initially evaluated in the ED. From this case series we determined the frequency of bacterial pathogens responsible for such infections in this age group. Pathogens were defined as group B streptococcus, various enteric gram-negative rods (GNRs), Listeria monocytogenes, enterococcus, Streptococcus pneumoniae, Neisseria meningitidis, Haemophilus influenzae type B, and Staphylococcus aureus. A subgroup analysis was performed to determine resistance patterns among the GNRs isolated from patients evaluated in the ED.

Results  A total of 367 pathogens were isolated: 187 (51.0%) in the neonatal intensive care unit, 153 (41.7%) in the ED, 20 (5.4%) in the inpatient wards, and 7 (1.9%) in the pediatric intensive care unit. Of the 121 pathogens isolated from 120 ED patients that were eligible for review, 94 (77.7%) were in the urine only, 16 (13.2%) in blood only, 4 (3.3%) in cerebrospinal fluid only, 3 (2.5%) in blood and cerebrospinal fluid, and 4 (3.3%) in blood and urine. Organisms isolated included GNRs (n=96, 79.3%), group B streptococcus (n=14, 11.6%), enterococcus (n=7, 5.8%), S pneumoniae (n=3, 2.5%), and N meningitidis (n=1, 0.8%). No Listeria were isolated. Of the 96 GNRs isolated, 60 (62.5%; 95% confidence interval, 52.8%-72.1%) were ampicillin resistant. All were sensitive to gentamicin sulfate and cefotaxime sodium.

Conclusions  Our results reveal 2 important facts: (1) during a 4-year period, no isolates of Listeria were identified from any patients 60 days or younger; and (2) of the 96 GNRs isolated from patients in the ED, more than 60% were ampicillin resistant. These data suggest that in similar centers with a low incidence of infection with Listeria and high levels of ampicillin resistance among GNRs, empiric use of ampicillin as part of a combination for presumed bacterial infections in patients 60 days or younger initially evaluated in the ED may be neither necessary nor beneficial. Consideration should be given to empiric initial antibiotic therapy using a third-generation cephalosporin with or without gentamicin.


From the Department of Pediatrics, George Washington University School of Medicine and Health Sciences, Children's National Medical Center, Washington, DC (Drs Sadow and Teach); and Departments of Pediatrics and Emergency Medicine, State University of New York at Buffalo School of Medicine, Children's Hospital of Buffalo (Dr Derr).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Invasive Pneumococcal Disease Among Infants Before and After Introduction of Pneumococcal Conjugate Vaccine
Poehling et al.
JAMA 2006;295:1668-1674.
ABSTRACT | FULL TEXT  

Expression and Activity of {beta}-Defensins and LL-37 in the Developing Human Lung
Starner et al.
J. Immunol. 2005;174:1608-1615.
ABSTRACT | FULL TEXT  

Risk Factors Associated With Ampicillin-Resistant Infection in Newborns in the Era of Group B Streptococcal Prophylaxis
Rentz et al.
Arch Pediatr Adolesc Med 2004;158:556-560.
ABSTRACT | FULL TEXT  

Serious Bacterial Infections in Febrile Infants Younger Than 90 Days of Age: The Importance of Ampicillin-Resistant Pathogens
Byington et al.
Pediatrics 2003;111:964-968.
ABSTRACT | FULL TEXT  

Ampicillin Use in Infant Fever: A Systematic Review
Brown et al.
Arch Pediatr Adolesc Med 2002;156:27-32.
ABSTRACT | FULL TEXT  

Choice of Antibiotics in Febrile Neonates
Del Vecchio et al.
Arch Pediatr Adolesc Med 2000;154:205-206.
FULL TEXT  

Ampicillin May No Longer Be Necessary in Neonatal Sepsis
JWatch Emergency Med. 1999;1999:2-2.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.